Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation.
about
Rational development of high-affinity T-cell receptor-like antibodiesStructural Basis for the Recognition of C20:2-αGalCer by the Invariant Natural Killer T Cell Receptor-like Antibody L363Therapeutic antibodies: current state and future trends--is a paradigm change coming soon?Display technologies: application for the discovery of drug and gene delivery agents.Human anti-gold antibodies: biofunctionalization of gold nanoparticles and surfaces with anti-gold antibodies.T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodiesImmune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cellsThe basic principles of chimeric antigen receptor design.A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody.Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential.Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody.Novel antibodies as anticancer agents.The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradationBispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future.Function and Potentials of M. tuberculosis EpitopesPotential antitumor applications of a monoclonal antibody specifically targeting human papilloma virus 16 E7 49-57 peptide.Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity.
P2860
Q27654241-94E115ED-E850-45A1-94D4-BD2627165DA6Q27675769-F5C52C92-788C-4EEB-8A60-2517A01EC6A8Q28728956-779A7566-45C3-475D-8CB5-DDB18548E420Q33264491-1232124C-D32F-471A-A1F7-0EA1333B435DQ33379776-2C4D214A-C554-4776-86CE-419D88A6092BQ33530527-210E8B2B-3E3F-4C95-8765-BD877C5BD0FAQ33610671-7E310BF2-7F26-489F-A226-BBA875451E65Q33614398-30E74380-A1D6-413D-B074-DFF10A1D5C62Q33927506-039E2F33-B41B-4ABB-A0D2-854ED368F201Q34036213-E9855D71-FE48-4994-9203-293D0C04F1B7Q34130082-704A13C2-DEEF-4CA4-BADA-7633133258B7Q35634680-EB9FE96F-27B5-441C-9773-ED044427783AQ35972322-210B81E9-FC77-4330-8A05-5FD00E24CD71Q36832141-49B0366E-86F2-4588-88DE-7AF91DB9BEAEQ36983796-AF9C5EAF-E278-457B-B2E7-0C1AECB17F4EQ38074885-747F89F7-8015-4985-B37C-3FE3C412CA86Q38203257-AE123C29-6E31-44E0-917C-4E9E5C9AEF33Q39370657-BD07B075-36B6-4CB9-B82E-80D027515A7BQ40196365-4C298CA4-296B-4587-B71F-EAE2205E3B3DQ52804817-1C445256-E23F-450A-A31F-63363643EABF
P2860
Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Recombinant antibodies with T- ...... tudy MHC class I presentation.
@ast
Recombinant antibodies with T- ...... tudy MHC class I presentation.
@en
type
label
Recombinant antibodies with T- ...... tudy MHC class I presentation.
@ast
Recombinant antibodies with T- ...... tudy MHC class I presentation.
@en
prefLabel
Recombinant antibodies with T- ...... tudy MHC class I presentation.
@ast
Recombinant antibodies with T- ...... tudy MHC class I presentation.
@en
P1433
P1476
Recombinant antibodies with T- ...... tudy MHC class I presentation.
@en
P2093
Galit Denkberg
Yoram Reiter
P304
P356
10.1016/J.AUTREV.2005.07.004
P577
2005-08-08T00:00:00Z